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What is the central question of this study? 
Fire service instructors are frequently exposed to live fire scenarios, representing the most extreme chronic 
occupational heat exposure. These individuals report a series of unique health issues. This study seeks to identify 
if the number of exposures completed are associated with inflammatory and immunological markers and 
symptoms of ill health. 
What is the main finding and its importance? 
Fire service instructors exhibit greater levels of inflammatory markers in comparison to firefighters. Fire exposure 
numbers are positively related with the prevalence of ill health and inflammation. Implementation of a proposed 
9 exposure limit per month may be appropriate to minimise health issues. 
ABSTRACT 
Fire Service Instructors (FSI) experience ~10 times more fire exposures than firefighters (FF), the increased 
physiological stress from this potentially puts them at risk of ill health and future cardiac events. This study aimed 
to establish whether FSI exhibit elevated biomarkers associated with cardiac event risk, identify if FSI experience 
systemic inflammation linked to fire exposure frequencies and evaluate a proposed exposure limit of 9 per month. 
Blood samples were collected from 110 Fire Service personnel (age: 44 ± 7 yrs; height: 178.1 ± 7.1 cm; body 
mass: 84.3 ± 12.0 kg, FSI n = 53, FF n = 57) for biomarker analysis. Work history details were collected from all 
participants. Participants with biomarker concentrations above healthy reference ranges were classified as “at 
risk”. Neutrophil/lymphocyte ratio, platelet count, cardiac troponin T, interleukin-6 (IL-6), interleukin-1β (IL-1β),
immunoglobulin G (IgG) and C reactive protein (CRP) were greater in FSI than FF (p<0.05). Multiple regression 
analysis revealed 18.8% of IL-6, 24.9% of IL-1β, 29.2% of CRP, and 10.9% of IgG variance could be explained 
by number of heat exposures per month. Odds ratios revealed that those above the 9 per month exposure limit 
were 6-12 times more likely to be classified as “at risk” and were 16 times more likely to experience symptoms 
of ill health. Increased cytokine levels suggest FSI experience systemic inflammation, which is related to
symptoms of ill health. We propose that an exposure limit could reduce the prevalence of these biomarker risk 
factors and ill health.
INTRODUCTION 
Within the UK Fire and Rescue Service, Fire Service Instructors (FSI) are responsible for the training of newly 
recruited and operational firefighters (FF). FSI regularly experience fire scenarios (commonly referred to as 
wears) to enable them to deliver training on breathing apparatus use, search and rescue techniques and fire 
behaviour. On average FSI report completing ~13 exposures a month, compared to ~1 fire incident attended by 
FF in the same period (Watkins, Hayes, Watt, & Richardson, 2018a). During exposures FSI typically experience 
maximum core temperatures of 37.9 – 38.5°C, with maximum heart rates of 134 – 147 b.min-1 (Eglin, Coles, & 
Tipton, 2004; Watkins, Hayes, Watt, & Richardson, 2019b; Watt et al., 2016); indicating that these individuals 
undergo a moderate level of physiological strain on a regular basis. 
A recent survey of FSI highlighted that 41% reported experiencing new symptoms of ill health since starting their 
career as a FSI (Watkins et al., 2018a). Symptoms included: severe fatigue, broken sleep, mood swings and 
headaches. Smith et al. (2000) hypothesised that symptoms such as these may be associated with chronic systemic 
inflammation when occurring in relation to repeated high volume physical strain without sufficient rest. However, 
it is difficult to ascertain whether inflammation is the cause of these symptoms, as there are limited possibilities 
to study individuals who experience high levels of strain over long periods of time (Carfagno & Hendrix, 2014).
Previous assessment of military recruits during training courses have identified symptoms, including sleep
disturbances, fatigue and confusion, that coincide with elevated interleukin-6 (IL-6), tumour necrosis factor alpha 
(TNFα) and C reactive protein (CRP) (Booth, Probert, Forbes-Ewan, & Coad, 2006; Gomez-Merino, Chennaoui, 
Burnat, Drogou, & Guezennec, 2003). The presence of elevated cytokine IL-6 has also been reported in FSI in
comparison to non-fire exposed controls (Watt et al., 2016; Watkins, Hayes, Watt, & Richardson, 2019a;),
although only a small sample of the FSI population have been assessed. 
Inflammation is linked to the presence of atherosclerosis and cardiovascular event risk (Moriya, 2019). Numerous 
haematological factors such as IL-6, CRP, and platelet counts (PLT) are involved in the inflammatory process and 
are also predictors of cardiovascular event risk (Pearson et al., 2003; Ridker, Rifai, Stampfer, & Hennekens, 2000; 
Sharma & Berger, 2011). FSI, along with FF, have an increased risk of a cardiovascular event following a live 
fire (Kales et al. 2007), it is also the leading cause of death within FF (Fahy, Leblanc, & Molis, 2015). Currently, 
research has focused on the immediate impact that live fire has to the risk of cardiac events (Fahs et al., 2011; 
Fernhall, Fahs, Horn, Rowland, & Smith, 2012; Hunter et al., 2017). Findings by Watt et al (2016) and Watkins 
et al., (2019b) highlight that FSI exhibit increases in PLT, IL-6, and cardiac troponin T (cTnT), a marker of cardiac 
muscle damage, after a training-based fire exposure, however the long term implications of this acute response 
are not yet fully understood. It can be theorised that if a live fire causes an increased risk, with minimal recovery 
time between fires, this risk may be elevated further by subsequent exposures if nothing is done to reduce the risk 
between events. It is therefore of importance to establish whether the number of fire exposures experienced is 
linked to an elevation in haematological markers associated with cardiovascular risk on a daily basis. 
The frequency of wear completion by FSI may be instrumental in the scale and time course of inflammation 
development. A survey of FSI highlighted that there is currently no evidenced based guidance on the number of 
wears a FSI should remain below in any given period (Watkins et al., 2018a). Although 55% of FSI did have a 
limit set by management, they varied across services from 2 - 10 per week. In the USA instructors have been 
reported to complete 3 -5 live fires per day over a period of several weeks or months (Fent et al., 2019). The most 
commonly reported limit to exposure numbers in the UK was 9 per month, which is not a formal policy, rather 
one proposed by the UK Chief Fire Officers’ Association (2015). Concerns regarding the number of wears 
performed was also a key theme when FSI offered their opinions about their working practices, with 35% of FSI 
indicating they felt that they completed too many wears. Being able to establish a suitable wear limit that might 
minimise the risk of fatigue symptoms occurring and reduce cardiac event risk factors, would enable evidence 
based guidelines for FSI across the world. Such information could have the potential to reduce FSI cardiac events 
risks and symptoms of ill health and prolong time spent in the career.
This study aimed to establish whether FSI exhibit an altered baseline immunological level compared to FF. In 
addition, it aimed to identify if altered immunological levels were related to the number of wears completed by 
FSI. The final aim of the study was to evaluate a proposed limit of 9 wears a month, to establish if completing 
wear numbers above or below this number was associated with immunological markers above upper reference 
ranges and reports of ill health. There are therefore four hypotheses within this study: (1) FSI will exhibit greater 
IL-6, CRP, cTnT and platelet volume and counts than FF, (2) increased fire exposure numbers will be correlated 
with elevated levels of cytokines, (3) those above the 9 wear limit will exhibit cytokine levels above the reference 
limits, and (4) there will be an association between immunological markers and reports of ill health. 
METHODS 
Ethical Approval 
One hundred and ten individuals (age: 44 ± 7 yrs; height: 178.1 ± 7.1 cm; body mass: 84.3 ± 12.0 kg) were 
recruited from Fire and Rescue Services across the UK to participate in the study. Of the 110 recruits, 53 were 
FSI (age: 45 ± 8 yrs; height: 176.6 ± 8.1 cm; body mass: 84.1 ± 8.1 kg) and 57 were FF (age: 44 ± 7 yrs; height: 
179.5 ± 5.8 cm; body mass: 84.4 ± 10.1 kg). Of the FSI, 47 (89%) were male and 6 (11%) were female. Of the 
FF, 55 (96%) were male and 2 (4%) were female. Independent fitness testing was not conducted as part of this 
research study, however all participants were operational personnel and therefore were required to meet national 
fitness standards. Fitness standards in the UK Fire and Rescue Service state that operational personnel should 
maintain a minimum maximal volume of oxygen uptake of 42 mL.kg-1.min-1 (Stevenson, Wilsher, & Sykes, 
2009), which is assessed in Service by trained staff. All participants took part in physical activity 2 – 3 times a 
week, with 32% reporting activity 4 – 5 times a week and 5% performing physical activity >5 times a week. 
Participants gave informed written consent and completed a medical questionnaire prior to taking part.
Participants were required to abstain from caffeine and exercise for 12 hours prior to the study commencing, they 
were also asked to avoid alcohol for 24 hours prior to taking part. Adherence to these parameters was checked via 
a questionnaire. The study was approved by the University of Brighton Research Ethics Committee (reference 
number: ESREGC/09/15) and conformed to the Declaration of Helsinki (2013), except for registration in a 
database. 
Experimental Design 
Participants provided a single venous blood sample and working history details on one occasion. This was 
collected at the Welkin Laboratories, University of Brighton or on location at Fire Stations and Fire Training 
Centres. Samples were collected from all FSI between 8:00 - 10:00am. Samples were collected from FF between 
8:00 - 10:00am or from 5:00 - 7:00pm, depending on their availability due to work requirements and rotas. All 
samples were collected prior to any heat exposure that day and a minimum of 12 hours post the last fire exposure. 
Venous Blood Collection 
A 10mL venous blood sample was taken at rest from the anti-cubital fossa by a trained phlebotomist. All samples 
were analysed within 2hr of collection for complete blood counts using an automated haematology analyser 
(XT2000i, Sysmex, UK) and then centrifuged at 4,500 rpm for 10 min at 4°C for plasma separation. Plasma was 
stored in a -86°C freezer for subsequent ELISA analyses of: IL-6, TNFα, IL1-β, CRP (R & D Systems, 
Minneapolis, USA) and IgG (eBioscience, Thermo Fischer Scientific, Massachusetts, USA). The inter-assay 
coefficient of variation (CV%) for each ELISA was: 5.5% IL-6, 8.7% TNFα, 11.5% IL-1β, CRP 11.7% and IgG 
6.0%. Plasma samples were also analysed for high sensitivity cTnT using an electrochemiluminescence assay 
[Roche Modular E170 (fifth generation), Basel, Switzerland], which had a blank of 3 ng.L-1 and CV at the upper 
reference limit (14 ng.L-1) of < 8% (Westermann, Neumann, Sörensen, & Blankenberg, 2017). Upper reference 
limits were identified for all haematological variables, with limits for variables measured via ELISA analysis 
increased by the corresponding inter-assay CV. IL-6 and CRP limits represent increased risk of a cardiovascular 
event. The upper quartile for IL-6 of 2.28pg.mL-1 was selected as Ridker et al., (2000) identified that those above 
this value have a 2.3 times higher relative risk of a future myocardial infarction than those in the lowest quartile. 
For CRP a value of >3 mg.L-1 was chosen as it represents the high risk category, with a 2 fold increase in relative 
risk of cardiovascular disease compared to those with < 1.0 mg.L-1 (Pearson et al., 2003). All other variable limits 
represent healthy upper reference ranges. Limits and their sources are detailed in Table 2.
Participant Details and Working History 
Participants were asked if in the previous month they had suffered from symptoms of ill health, identified by 
Watkins et al., (2018a) (fatigue, broken sleep, heavy sweating, heart palpitations, mood swings, coughing, and 
breathing problems) or any other illnesses. Participants were also asked to provide a brief work history. Details 
of their time in the Fire and Rescue Service, if they were currently a FSI, and the time they had spent in their 
current role were collected. Participants also reported how many fire exposures (in either a training or operational 
capacity) they had completed in the previous week and in the last month. 
Statistical Analysis 
Data were analysed using IBM SPSS Statistics 22 and presented as mean ± SD, unless otherwise stated. Data were 
tested for normality and sphericity. Differences in haematological variables between FSI and FF were assessed 
via independent samples t-tests, or Mann-Whitney U tests when data were not normally distributed. Cohens ds
effect sizes are presented for t-test comparisons (Lakens, 2013) whilst r effect sizes are given for Mann-Whitney 
U tests (Field et al., 2009), effect sizes are interpreted as recommended by Cohen (1988). Pearson’s chi-squared 
analysis was conducted to establish if there was an association between occupational group (FSI vs FF) and 
occurrence of symptoms of ill health (YES vs NO), with subsequent odds ratios conducted where significant 
associations occurred. 
Multiple regression analysis was conducted to identify the relationship between work history and demographic 
variables (BMI, age, time in service, number of wears completed per week, number of wears completed per month) 
with haematological dependent variables. Where dependent variables did not meet normality assumptions 
bootstrap re-sampling was conducted. Where significant regression models were identified, regression coefficient 
statistical significance was interrogated for each predictor variable. Regression analysis was then rerun with only 
significant predictor variables to define the model. 
Haematological markers identified as predicted from exposure numbers had data classified as either above (“at 
risk”) or below (“healthy”) upper reference range values (see Table 2). To evaluate the effectiveness of the current 
FSI proposed limit of 9 wears a month, Pearson’s chi squared analysis was conducted to identify associations 
between those performing ≤ 9 or > 9 exposures a month and those in the “at risk” or “healthy” groups. Pearson’s 
chi squared analysis was also conducted to determine if reference range groups (“at risk” vs “healthy”) were 
associated with ill health symptoms, with follow up odds ratios conducted for significant associations. An a priori 
power analysis was performed using previously reported differences in IL-6 between FSI and a control group 
(Watkins et al., 2019a), on the basis of the effect size (Cohen’s d = 1.11) associated with those differences and a 
statistical power of 80% a minimum of 28 participants were required. Due to the limited previous data available 
for the association of the specific symptoms of ill health with elevated cytokine levels, an a priori test based on a 
chi squared analysis with a medium effect (w = 0.3) and 80% power was conducted, identifying that a minimum 
of 88 participants were required. Significance level was set at p < 0.05.
RESULTS 
Differences between FSI and FF 
FSI and FF had similar demographic details (Table 1). FSI had completed a greater number of fire exposures in 
the previous week and month (p < 0.001) in comparison to FF (Table 1). The maximum number of exposures 
completed in a week and month by FSI were 8 and 20, respectively. In total 37 (69%) FSI were within the 
suggested limit of ≤ 9 wears per month, whilst 16 were not. No FF completed > 3 exposures per month. 
Reports of ill health were made by 3 (5%) FF and 16 (30%) FSI. FF who reported illness all reported colds. Of 
the FSI who reported illness, 10 (19%) had severe fatigue, 8 (15%) had a cold, 8 (15%) had broken sleep, 4 (8%) 
suffered from a cough, 4 (8%) had heavy sweating, 2 (4%) had mood swings, 1 (2%) suffered from heart 
palpitations and 1 (2%) had sinusitis. Pearson’s chi squared analysis revealed a significant association between 
group and presence of illness (χ² (1) =11.941, p = 0.001), with FSI 7.78 (95% CI 2.12 - 28.62) times more likely 
to have a symptom of ill health than FF. 
Analysis of CBC between FSI and FF revealed increased levels of NEUT (p = 0.029), PLT (p < 0.001), BASO (p
= 0.003), and neutrophil lymphocyte ratio (NLR) (p = 0.044) in FSI compared to FF. FF had increased levels of 
EO (p = 0.032) than FSI. Analysis of other haematological variables revealed increases in cTnT (p < 0.001), IL-
6 (p = 0.002), IL-1β (p = 0.006), CRP (p = 0.005), and IgG (p < 0.001) in comparison to FF. See Table 2 for 
details of haematological levels. 
Relationship between Deterministic Variables and Haematological Markers 
Multiple regression analysis of haematological variables revealed significant models for IL-6, IL-1β, CRP and 
IgG only (p < 0.05). For these four haematological markers, age, time in service, and week exposure number were 
not predictor variables (p > 0.05). Following remodeling with only significant predictors, month exposure number 
explained 18.8% of IL-6 variance, 24.9% of IL-1β variance, 29.2% of CRP variance, and 10.9% of IgG variance 
(see Figure 1). BMI also explained an additional 3% of CRP variance.
“At Risk” Reference Values Associated with Wear Limits and Ill Health 
Haematological variables related to monthly wear numbers (IL-6, IL-1β, CRP and IgG) were grouped according 
to the upper reference range criteria. Those below the reference limit were classified as the “healthy” group, whilst
those above were classified as the “at risk” group. The current suggested monthly wear limit of 9 wears was 
associated with groupings for IL-6, IL-1β, CRP and IgG, see Table 3 for the association statistics and odds ratios. 
The 9 wear monthly limit was also associated with the presence of symptoms of ill health (χ² (1) = 26.803, p <
0.001). Those above the wear limit were 15.74 times (95% CI 2.26 - 32.80) more likely to suffer symptoms of ill 
health than those below the limit. The reference limit groupings for IL-6, IL-1β, CRP and IgG were also associated 
with the presence of symptoms of ill health, see Table 4 for the association statistics and odds ratios. 
DISCUSSION 
This study aimed to evaluate the concentrations of immunological markers related to health problems in FSI and 
FF in association with exposure history and the proposed 9 wears per month limit. Differences in numerous 
immunological markers were noted between FSI and FF, with FSI having greater levels of biomarkers associated 
with future cardiac events, such as NLR, IL-6 and CRP. In addition, monthly wear numbers were positively related 
to IL-6, IL-1β, CRP and IgG concentrations. The current proposal of a 9 wear limit may be reasonable, with those 
above the limit more likely to be in “at risk” groups for raised IL-6, IL-1β, CRP and IgG. Moreover, those in “at 
risk” groups were more likely to experience symptoms of ill health. 
Of the FSI involved in this study, 30% reported symptoms of ill health, compared to 5% of FF. The occurrences 
reported are lower than the 41% of FSI and 21% of FF who reported ill health in a previous survey of fire service 
personnel (Watkins et al., 2018a). However, that survey referred to frequent symptoms since the beginning of 
their job role, whereas this study gathered information of symptoms experienced within the previous month. The 
type of symptoms reported in this study are however similar to that previously referred to, reaffirming the 
prevalence of a set of symptoms in the FSI population different from their FF counterparts. Comparison of FSI 
and FF resting haematological variables revealed that NEUT, PLT, BASO, NLR, cTnT, IL-6, IL-1β, CRP, and 
IgG were all greater in FSI. 
Acute Inflammatory and Haematological Changes with Heat Exposure 
Numerous previous studies offer an assessment of haematological and inflammatory responses to heat exposure. 
Following live fire exposures an increase of 19 – 85% in WBC and 32 – 54% in NEUT have typically been 
reported, with extended durations and greater temperatures resulting in larger increases when comparing studies 
(Smith, Petruzzello, Chludzinski, Reed, & Woods, 2005; Smith et al., 2011; Watkins et al., 2019b; Watt et al., 
2016). Inflammatory markers such as IL-6 have also been noted to increase by 25 – 27% with live fire exposure 
(Walker et al., 2015; Watkins et al., 2019b; Watt et al., 2016).
The elevation of these markers has been postulated to be stimulated through numerous mechanisms. 
Sympathoadrenal activation, as a result of physiological strain, increases circulating catecholamines, which can 
reduce the interaction between leukocytes and endothelial cells and consequently cause the demargination of 
leukocytes from the vasculature (Shephard, 2003; Smith et al., 2005; Walsh & Whitham, 2006). Tissue damage 
can stimulate an inflammatory response, with endothelial cells releasing IL-6 and subsequently stimulating the 
release other inflammatory markers, such as C-reactive protein, and leukocyte transmigration as part of the acute 
phase response reaction (Bruunsgaard et al., 1997). However, it is now well documented that muscles release IL-
6 during exercise and periods of elevated temperature without the presence of tissue damage (Fischer, 2006; 
Petersen & Pedersen, 2005; Welc et al., 2012). Endotoxin release from the gut during exercise with heat stress is
also proposed as a stimulant for inflammation (Snipe, Khoo, Kitic, Gibson, & Costa, 2018; Starkie, Hargreaves, 
Rolland, & Febbraio, 2005). Research suggests that whilst these haematological markers may remain altered 
compared to baseline in the hours immediately following exposure, by 24 hours they typically have returned to 
resting levels (Walker et al., 2015). Consequently additional exposures with minimal recovery could result in the 
baseline elevations reported in this study. 
Cardiovascular Event Risk 
An increased NLR represents neutrophilia, also indicated by the noted increase in NEUT, in combination with 
lymphocytopaenia, and is an indicator of systemic inflammation (Guthrie et al., 2013). NLR is known to increase 
following acute exercise, remaining elevated but returning towards normal values 6 hrs post exercise (Nieman, 
1998; Nieman, 2000). Neutrophils are involved in all stages of atherosclerosis, they increase the expression of 
adhesion molecules, limit vasodilation, and can lead to atherosclerotic plaque instability, making the plaque prone 
to rupture (Soehnlein, 2012). In contrast, regulatory T cell lymphocytes are involved in the inhibition of 
atherosclerosis by regulating the inflammatory response and therefore low lymphocyte counts represent a poorly 
regulated immune response (Shah et al., 2014). Consequently, the combined ratio of these two white blood cells 
acts as an independent predictor of cardiac mortality in patients with coronary artery disease (Papa et al., 2008),
those with acute decompensated heart failure (Uthamalingam et al., 2011), patients with myocardial infarctions 
(Bhat et al., 2013), and in a healthy general population (Shah et al., 2014). Within a healthy population, higher 
NLR is associated with a greater incidence of coronary heart disease related deaths, with an NLR >4.5 associated 
with 11% of deaths compared to 3.2% of deaths with an NLR of 1.5 – 3.0 and 2.4% of deaths in those with an 
NLR of <1.5 (Shah et al., 2014). The upper range of NLR in a healthy population is 3.53, however an NLR >4.5 
is associated with a hazard ratio for future cardiac events of 2.68 (Forget et al., 2017; Shah et al., 2014). Fest et 
al., (2019) also states that being in the 3rd (1.60 – 1.91), 4th (1.92 – 2.41) and 5th (>2.41) quartiles for NLR 
increased all cause mortality in comparison to the 1st quartile (<1.30). Whilst the exact values attributed to quartiles 
and high NLR are study dependent, FSI in this study exhibit a greater NLR (2.12) than FF (1.83), suggesting that 
FSI may be at a greater risk of a cardiovascular event than FF. 
Elevated cTnT in FSI indicates possible low level myocardial damage. Baseline resting measurements of cTnT 
from healthy populations indicate typical levels of < 10 ng.L-1 in marathon runners (Neilan et al., 2006; Richardson 
et al., 2018) and 6.2 ± 2.2 ng.L-1 in elite floorball players (Wedin & Henriksson, 2015). This suggests that cTnT 
exhibited by FF and FSI are both below the healthy upper limit (< 14 ng.L-1) and within the range of other healthy 
active population groups. Increased resting levels of cTnT in healthy individuals are related to left ventricular wall 
thickening and left ventricular systolic dysfunction, in addition to all cardiovascular mortality (de Lemos et al., 
2010). With each tertile increase of cTnT from non-detectable to > 14 ng.L-1, the hazard ratio of cardiovascular 
mortality increases. Those with cTnT between 3 - 4.4 ng.L-1 have a hazard ratio of 1.6 (95% CI 0.5 - 4.9), a cTnT 
of 4.4 - 6.6 ng.L-1 suggests a ratio of 2.4 (95% CI 0.9 - 6.1), and individuals with cTnT 6.6 - 14 ng.L-1 the hazard 
ratio of cardiovascular mortality is 4.6 (95% CI 2.1 - 10.0) (de Lemos et al., 2010). FF consequently have a lower 
hazard ratio of cardiovascular mortality than FSI, with FF exhibiting 3.00 ± 1.32 ng.L-1 and therefore either falling 
in undetectable levels or within the first detectable tertile of 3 - 4.4 ng.L-1, compared to FSI who exhibited 4.41 ±
2.68 ng.L-1 giving the average FSI a hazard ratio of 2.4. 
MPV is also associated with incidence of myocardial infarction and coronary artery disease (Klovaite, Benn, 
Yazdanyar, & Nordestgaard, 2011; Sansanayudh et al., 2014). However, MPV displayed no differences between 
FSI and FF and although FSI PLT (234 ± 79 x109.L-1) was greater than FF PLT (190 ± 35 x109.L-1), it remained 
below the upper reference range. This is similar to the PLT noted in previous FF studies of 264 ± 53 x109.L-1
(Smith et al., 2011), 257 ± 62 x109.L-1 (Smith et al., 2014) and 241 ± 11 x109.L-1 (Hunter et al., 2017), and resting 
PLT previously reported in FSI (209 ± 43 x109.L-1) (Watkins et al., 2019b). Consequently demonstrating that 
whilst elevated PLT has been noted post fire exposure (Smith et al., 2011; Hunter et al 2017; (Watkins et al., 
2019b), this increase is transient with minimal effect on daily baseline levels. 
A key finding of this study is the significantly elevated levels of inflammatory cytokines IL-6, IL-1β and acute 
phase protein CRP, in FSI. IL-6 is involved in the increase of cell adhesion molecules, platelet reactivity and CRP 
release, and therefore may be involved in atherosclerosis formation (Lindmark, Diderholm, Wallentin, & 
Siegbahn, 2001; Schuett, Luchtefeld, Grothusen, Grote, & Schieffer, 2009). FSI exhibited a mean IL-6 of 1.66 ±
2.29 pg.mL-1, in the third quartile of values reported in apparently healthy men (1.47 – 2.28 pg.mL-1), such 
concentrations have been linked to a 2.8 times higher risk of myocardial infarction (Ridker et al., 2000). IL-6
levels in FSI reported in this study are not as great as those reported at rest by Watt et al (2016) (7.4 – 17.0 pg.mL-
1). However, this present study included FSI with an average of 6 ± 5 exposures a month, whereas FSI who 
participated in the study conducted by Watt et al (2016) had completed 15 wears in a 4 week period. The 
participants therefore experienced a greater number of exposures than the average experienced by the FSI involved 
in this study, further supporting the positive correlation identified between exposure number and IL-6 values. 
IL-1β is also involved in increasing the expression of adhesion molecules, inducing procoagulant activity, and the 
stimulation of CRP synthesis and release (Jialal, Devaraj, & Venugopal, 2004; Ridker, Thuren, Zalewski, & 
Libby, 2011). Although IL-1β has not yet been established as a predictor of cardiovascular events with set 
classifications of risk, perhaps due to the variability in its measurement in plasma (Ridker et al., 2011), gene 
polymorphisms causing increased IL-1β are associated with risk of coronary artery disease and cardiovascular 
events (Tsimikas et al., 2014). There is some effort to target IL-1β for atheroprotective interventions and there is 
some underpinning evidence for its involvement in raised risk (Ridker, 2016). This current study is the first study 
to identify elevated IL-1β levels in FSI. 
CRP has also been detected in atherosclerotic lesions (Yasojima, Schwab, McGeer, & McGeer, 2001) and elevated 
levels have been reported to correlate with increased adhesion molecules and lower endothelium-dependent 
vasodilatory responses (Fichtlscherer et al., 2000; Jialal et al., 2004), although it is unlikely CRP is causal in these 
endothelial changes (Danesh & Pepys, 2009; Taylor, Giddings, & Van Den Berg, 2005). Whilst the mean CRP 
exhibited by FSI was 1.62 ± 2.40 mg.L-1, the variation in levels was high (as demonstrated by the large SD). Of 
the FSI, 26.4% of individuals displayed CRP > 3.0 mg.L-1 in comparison to just 3.5% FF. CRP > 3.0 mg.L-1
-1indicates a 2 fold increase in relative risk of cardiovascular disease compared to those with CRP < 1.0 mg.L
(Pearson et al., 2003). The elevated presence of IL-6, IL-1β, and CRP therefore demonstrates FSI experience 
chronic systemic inflammation and are at an increased risk of cardiovascular events. 
Wear Limits 
The measured concentration of IL-6, IL-1β, CRP and IgG were related to the number of wears that had been 
completed in the previous month, with 11 - 29% of variance in these markers explained by wear numbers. These 
findings support the theory that performing a greater number of fire exposures is associated with increased 
cytokine levels. The wear limit informally proposed and followed by some training centres is 9 wears per month 
(Watkins et al., 2018a). The evaluation of this limit indicates that those above the limit are more likely to be in 
the “at risk” group for IL-6 (OR = 6.27), IL-1β (OR = 7.00), CRP (OR = 12.43) and IgG (OR = 7.55). This 
suggests that those FSI conducting a greater number of wears may be at an increased risk of a future cardiovascular 
event. Moreover, our data suggests that individuals completing > 9 wears a month are 15.74 times more likely to 
suffer symptoms of ill health than those below the limit. 
Health Symptoms 
The “at risk” groups for IL-6, IL-1β, CRP, and IgG were also associated with an increased likelihood of 
experiencing symptoms of ill health, such as fatigue, sleep disturbances, headaches, colds and flu like illnesses 
(IL-6 OR = 5.63, IL-1β OR = 3.67, CRP OR = 6.05, IgG OR = 6.45). These symptoms are comparable to “sickness 
behaviours”, such as depression, fatigue and sleep disturbances, which are a consequence of the ability of 
inflammatory cytokines to effect central nervous system function. This may occur through numerous pathways, 
including: the transportation of cytokines across the blood brain barrier via cytokine receptors, stimulation of 
afferent nerves such as the vagus nerve and entering the brain via volume diffuse at circumventricular organs 
(Dantzer, O’Connor, Freund, Johnson, & Kelley, 2008; Johnson, 2002). Within both a military and sporting 
environment similar findings have been reported, with sleep disturbances, depressed mood and fatigue occurring 
with elevated levels of IL-1β, TNFα, CRP and IL-6 following repeated high levels of physiological strain (Booth 
et al., 2006; Gomez-Merino et al., 2003). Consequently, this study indicates that the symptoms reported by FSI 
may be related to systemic inflammation. 
Cold and cough symptoms reported by FSI also suggest the possibility that immune function may be altered; it
has previously been proposed that following periods of high physical strain humoral immunity is up-regulated 
and consequently cellular immunity is suppressed, increasing the risk of viral or bacterial infection (Buyukyazi et 
al., 2004; Smith, 2004). An increase in humoral immunity may also be related to an increase in allergies and 
immunoglobulins (Smith, 2004). IgG was elevated in FSI (1649 ± 865 mg.dL-1) in comparison to FF (835 ± 695 
mg.dL-1), possibly indicating increased humoral immunity and inflammation. However, the balance between 
cellular and humoral immunity is also carefully controlled by the regulation of specific cytokines. IL-2, IL-12 
and interferon gamma (IFNγ) are crucial in the development of Th1 cells that are instrumental in cellular 
immunity, and IL-4, IL-5, IL-10, IL-6, and TNFα being involved in the development of Th2 cells that are involved 
in humoral immunity (Kidd, 2003; Lucille Lakier Smith, 2003). Whilst the elevated IL-6 in FSI could support the 
possible increase in humoral immunity, a larger array of cytokines and other biomarkers should be investigated 
in future studies to further understand the balance between humoral and cellular immunity in FSI. 
Limitations 
Unlike IL-6, IL-1β, CRP and IgG some haematological variables that were greater in FSI than FF were not 
statistically associated with number of wears completed, or with any other demographic or work history details.
In addition, not all variation in IL-6, IL-1β, CRP, and IgG was explained by monthly exposure numbers. It is 
reasonable to suggest that there are many other factors that were outside of the scope of this specific study that 
may have influenced these variables, such as the overall thermal load experienced from the wears completed, the 
type of wears completed (Watkins et al., 2019b), level of smoke/particulate exposure, stress levels of participants, 
and FSI use of hydration guidance, clothing (Watkins & Richardson, 2017) and pre/post cooling interventions 
(Watkins, Hayes, Watt, & Richardson, 2018b) for each wear performed. Stress, anxiety and depression have also 
previously been associated with systemic inflammation (Majd, Saunders, & Engeland, 2019; Renna, O’Toole, 
Spaeth, Lekander, & Mennin, 2018), but were not measured in this study. It is unknown if levels of these 
psychological conditions differ between FF and FSI. Future research should further explore the influence that 
other factors may have on systemic inflammation in FSI. 
Participants who reported themselves as FSI were classified as such, regardless of wear exposure number, to 
ensure the data represented the FSI population. This resulted in two FSI with no wear completions in the previous 
month being included in the FSI group, despite them having a lower monthly wear number than the FF group 
mean. Due to the logistical difficulty of accessing this population and cost of blood sample analysis this study 
offers only a singular snapshot of FSI and FF immunological status. Presence of symptoms of ill health were also 
subjective and not verified by a medical professional. Furthermore, there are many risk factors of cardiovascular 
events, of which not all were collected in this study. The duration between wears was also not detailed as part of 
this study and should be included in future research. Overall, it is suggested that long term monitoring should be 
conducted to establish if any additional extraneous variables are associated with haematological values.
CONCLUSION 
In conclusion, FSI specifically need to be targeted for interventions to help reduce the occurrence of elevated 
haematological measures, as findings from this study suggest they are at an increased risk of a future 
cardiovascular event and symptoms of ill health compared to FF. Moreover, increased levels of IL-6, IL-1β, CRP, 
and IgG are associated with the number of wears FSI complete in a month. The current suggestion of a 9 wear per 
month limit seems a reasonable guidance, as those above the limit are 15.74 times more likely to experience 
symptoms of ill health. Future research should investigate the impact that interventions designed to reduce the 
thermal load from frequent fire exposures have on the chronic systemic inflammation prevalent in FSI. 
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TABLES 
Table 1 Demographic and work history details for firefighters and fire service instructors. a denotes values 
displayed are median ± IQR. * denotes a difference between the two groups, p < 0.05. 
Fire Service Instructors Firefighters 
Age (yrs) 45 ± 8 44 ± 7 
Body mass (kg) 84.1± 13.8 84.4 ± 10.1 
BMI (kg.m2) 26.5 ± 5.1 a 25.4 ± 3.5 a
Time in Service (yrs) 19 ± 8 17 ± 7 
Time in role (yrs) 3 ± 8 a * 10 ± 10 a
Weekly Exposures 1 ± 3 a * 0 ± 0 a
Monthly Exposures 5 ± 8 a * 1 ± 1 a
Table 2 Resting levels of haematological variables in FSI and FF. a denotes values displayed are median ± IQR. 
Effect size is given as ds, unless the variable is presented as median ± IQR, whereby the corresponding effect size 
is r. * denotes a difference between groups, p < 0.05.† denotes median value is greater than upper reference value. 
Upper limit for WBC, RVC, HGB, HCT, NEUT, LYMPH, MONO, EO and BASO from Bain et al. (2011), PLT 
and MPV from Briggs et al. (2007), NLR from Forget et al. (2017), cTnT from Zhelev et al. (2015), IL-6 from 
Ridker et al. (2000), TNFα from Todd et al. (2013), IL-1β from Di Iorio et al. (2003) and La Fratta et al. (2018),
CRP from Pearson et al. (2003) and IgG from Fuggle (2017).
Fire Service Firefighters Effect Size Upper Reference 
Instructors Limit 
WBC (x109.L-1) 6.56 ± 2.10 a 6.47 ± 1.73 a 0.09 10.0 
PLT (x109.L-1) 234 ± 79 a * 190 ± 35 a 0.49 400
MPV (fL) 10.0 ± 0.9 10.3 ± 0.7 0.37 11.2 
NEUT (x109.L-1) 3.85 ± 1.20 a * 3.54 ± 1.18 a 0.18 7.0 
LYMPH (x109.L-1) 1.97 ± 0.52 1.97 ± 0.52 0 3.0 
MONO (x109.L-1) 0.59 ± 0.26 a 0.57 ± 0.19 a 0.01 1.0 
EO (x109.L-1) 0.13 ± 0.15 a * 0.18 ± 0.13 a 0.20 0.5 
BASO (x109.L-1) 0.05 ± 0.05 a * 0.03 ± 0.03 a 0.28 0.1 
NLR 2.12 ± 0.84* 1.83 ± 0.63 0.19 3.53 
cTNT (ng.L-1) 4.41 ± 2.68 a * 3.00 ± 1.32 a 0.40 14
IL-6 (pg.mL-1) 1.66 ± 2.26 a * 0.93 ± 1.29 a 0.28 2.41 
TNFα (pg.mL-1) 3.31 ± 5.42 a 2.56 ± 2.40 a 0.14 3.59 
IL-1β (pg.mL-1) 2.50 ± 9.99 a *† 0.00 ± 2.35 a 0.24 1.00 
CRP (mg.L-1) 1.62 ± 2.40 a * 0.77 ± 0.88 a 0.13 3.35 
IgG (mg.dL-1) 1649 ± 865 a * 835 ± 695 a 0.49 1696
WBC = white blood cell count, PLT = platelet count, MPV = mean platelet volume, NEUT = neutrophil count, 
LYMPH = lymphocyte, MONO = monocyte, EOS = eosinophil, BASO = basophil, NLR = neutrophil lymphocyte 
ratio, cTnT = cardiac troponin T, IL-6 = interleukin-6, TNFα= tumour necrosis factor alpha, IL-1β= interleukin-
1 beta, CRP = C  reactive protein, IgG = immunoglobulin G. 
Table 3 Association between monthly wear limit (≤ or > 9 wears per month) and participants IL-6, IL-1β, CRP 
and IgG above or below upper reference levels. Odds ratios based on likelihood of those completing >9 wears per 






Odds Ratio (95% CI) 
6.27 (2.04 – 19.3) 
IL-1β 7.784 0.004 * 7.00 (1.51 – 32.51) 
CRP 21.023 0.001 * 12.43 (3.57 – 43.22) 
IgG 14.563 0.001 * 7.55 (2.41 – 23.61) 
IL-6 = interleukin-6, IL-1β = interleukin-1 beta, CRP = C reactive protein, IgG = immunoglobulin G 
Table 4 Association between haematological group (above or below reference limits) with the presence of 
symptoms of ill health. Odds ratios based on the likelihood of those above reference limits exhibiting symptoms 






Odds Ratio (95% CI) 
5.63 (1.96 – 16.20) 
IL-1β 5.131 0.040 * 3.67 (1.13 – 11.90) 
CRP 10.507 0.004 * 6.05 (1.86 – 19.72) 
IgG 13.792 0.001 * 6.45 (2.24 – 18.58) 
IL-6 = interleukin-6, IL-1β = interleukin-1 beta, CRP = C reactive protein, IgG = immunoglobulin G 
FIGURES 
Figure 1 IgG (A), IL-1β (B), IL6 (C) and CRP (D) plotted against monthly wear number. Green zone represents 
the “healthy” range for each variable, as identified in Table 2. Vertical grey dashed line represents the 9 exposure 
limit. IL-6 = interleukin-6, CRP = C reactive protein, IL-1β = interleukin-1 beta, IgG = immunoglobulin G.
